Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Hemoglobinopathies Market Report by Type (Thalassemia, Sickle Cell Disease, and Others), Treatment (Blood Transfusion, Stem-cell Transplantation, Analgesics, Antibiotics, ACE Inhibitors, Hydroxyurea, and Others), Test Type (Red Blood Cell (RBC) Count, Genetic Testing, High Performance Liquid Chromatography (HPLC), Hemoglobin Isoelectric Focusing (Hb IEF), Hemoglobin Electrophoresis (Hb ELP), Hemoglobin Solubility Test), End User (Hospitals and Clinics, Diagnostics Laboratories, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A5123
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Hemoglobinopathies Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Thalassemia
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Alpha Thalassemia
6.1.2.2 Beta Thalassemia
6.1.3 Market Forecast
6.2 Sickle Cell Disease
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Treatment
7.1 Blood Transfusion
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Stem-cell Transplantation
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Analgesics
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Antibiotics
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 ACE Inhibitors
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Hydroxyurea
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by Test Type
8.1 Red Blood Cell (RBC) Count
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Genetic Testing
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 High Performance Liquid Chromatography (HPLC)
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Hemoglobin Isoelectric Focusing (Hb IEF)
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Hemoglobin Electrophoresis (Hb ELP)
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Hemoglobin Solubility Test
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals and Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Diagnostics Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Bio-Rad Laboratories Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 bluebird bio Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bristol-Myers Squibb Company
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Danaher Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Emmaus Life Sciences Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.6 Gamida-Cell Ltd.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.7 Global Blood Therapeutics Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8 Novartis AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 PerkinElmer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Prolong Pharmaceuticals LLC
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 Sangamo Therapeutics Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 Sysmex Corporation
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
15.3.13.4 SWOT Analysis
List of Figures
Figure 1: Global: Hemoglobinopathies Market: Major Drivers and Challenges
Figure 2: Global: Hemoglobinopathies Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Hemoglobinopathies Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Hemoglobinopathies Market: Breakup by Type (in %), 2023
Figure 5: Global: Hemoglobinopathies Market: Breakup by Treatment (in %), 2023
Figure 6: Global: Hemoglobinopathies Market: Breakup by Test Type (in %), 2023
Figure 7: Global: Hemoglobinopathies Market: Breakup by End User (in %), 2023
Figure 8: Global: Hemoglobinopathies Market: Breakup by Region (in %), 2023
Figure 9: Global: Hemoglobinopathies (Thalassemia) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Hemoglobinopathies (Thalassemia) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Hemoglobinopathies (Sickle Cell Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Hemoglobinopathies (Sickle Cell Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Hemoglobinopathies (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Hemoglobinopathies (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Hemoglobinopathies (Blood Transfusion) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Hemoglobinopathies (Blood Transfusion) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Hemoglobinopathies (Stem-cell Transplantation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Hemoglobinopathies (Stem-cell Transplantation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Hemoglobinopathies (Analgesics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Hemoglobinopathies (Analgesics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Hemoglobinopathies (Antibiotics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Hemoglobinopathies (Antibiotics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Hemoglobinopathies (ACE Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Hemoglobinopathies (ACE Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Hemoglobinopathies (Hydroxyurea) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Hemoglobinopathies (Hydroxyurea) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Hemoglobinopathies (Other Treatments) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Hemoglobinopathies (Other Treatments) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Hemoglobinopathies (Red Blood Cell (RBC) Count) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Hemoglobinopathies (Red Blood Cell (RBC) Count) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Hemoglobinopathies (Genetic Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Hemoglobinopathies (Genetic Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Hemoglobinopathies (High Performance Liquid Chromatography-HPLC) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Hemoglobinopathies (High Performance Liquid Chromatography-HPLC) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Hemoglobinopathies (Hemoglobin Isoelectric Focusing-Hb IEF) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Hemoglobinopathies (Hemoglobin Isoelectric Focusing-Hb IEF) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Hemoglobinopathies (Hemoglobin Electrophoresis-Hb ELP) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Hemoglobinopathies (Hemoglobin Electrophoresis-Hb ELP) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Hemoglobinopathies (Hemoglobin Solubility Test) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Hemoglobinopathies (Hemoglobin Solubility Test) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Global: Hemoglobinopathies (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Global: Hemoglobinopathies (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Global: Hemoglobinopathies (Diagnostics Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Global: Hemoglobinopathies (Diagnostics Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Global: Hemoglobinopathies (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Global: Hemoglobinopathies (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: North America: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: North America: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: United States: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: United States: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Canada: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Canada: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Asia-Pacific: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Asia-Pacific: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: China: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: China: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Japan: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Japan: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: India: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: India: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: South Korea: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: South Korea: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Australia: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Australia: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Indonesia: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Indonesia: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Others: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Others: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Europe: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Europe: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Germany: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Germany: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: France: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: France: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: United Kingdom: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: United Kingdom: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Italy: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Italy: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Spain: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Spain: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Russia: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Russia: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Others: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Others: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Latin America: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Latin America: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Brazil: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Brazil: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Mexico: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 90: Mexico: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 91: Others: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 92: Others: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 93: Middle East and Africa: Hemoglobinopathies Market: Sales Value (in Million US$), 2018 & 2023
Figure 94: Middle East and Africa: Hemoglobinopathies Market: Breakup by Country (in %), 2023
Figure 95: Middle East and Africa: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 96: Global: Hemoglobinopathies Industry: SWOT Analysis
Figure 97: Global: Hemoglobinopathies Industry: Value Chain Analysis
Figure 98: Global: Hemoglobinopathies Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Hemoglobinopathies Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Hemoglobinopathies Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Hemoglobinopathies Market Forecast: Breakup by Treatment (in Million US$), 2024-2032
Table 4: Global: Hemoglobinopathies Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
Table 5: Global: Hemoglobinopathies Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Hemoglobinopathies Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Hemoglobinopathies Market: Competitive Structure
Table 8: Global: Hemoglobinopathies Market: Key Players
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More